| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Awareness, treatment, and control of hypertension in Canada.
|
Am J Hypertens
|
1997
|
4.76
|
|
2
|
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient.
|
Can J Cardiol
|
2004
|
1.44
|
|
3
|
Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison.
|
Am J Prev Med
|
1988
|
1.44
|
|
4
|
Clinical assessment of blood pressure.
|
J Hum Hypertens
|
1990
|
1.41
|
|
5
|
Surveillance for stroke in Canada.
|
Health Rep
|
1994
|
1.30
|
|
6
|
Self-measurement of blood pressure: benefits, risks and interpretation of readings. The Canadian Coalition for High Blood Pressure Prevention and Control.
|
Can J Cardiol
|
1995
|
1.17
|
|
7
|
Lack of control of high blood pressure and treatment recommendations in Canada.
|
Can J Cardiol
|
2002
|
1.15
|
|
8
|
Adherence to pharmacologic management of hypertension.
|
Can J Public Health
|
1999
|
1.12
|
|
9
|
Genetic diversity of Toxoplasma gondii isolates from chickens from Brazil.
|
Vet Parasitol
|
2008
|
1.12
|
|
10
|
Guidelines for measurement of blood pressure, follow-up, and lifestyle counselling. Canadian Coalition for High Blood Pressure Prevention and Control.
|
Can J Public Health
|
1995
|
1.00
|
|
11
|
Changes in the patterns of blood pressure treatment in North America from 1960-1990.
|
J Hum Hypertens
|
1993
|
0.95
|
|
12
|
Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
|
CMAJ
|
1999
|
0.94
|
|
13
|
Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group.
|
Cardiovasc Drugs Ther
|
1995
|
0.93
|
|
14
|
Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
|
Can J Cardiol
|
1999
|
0.93
|
|
15
|
Self-measurement of blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control.
|
Can J Cardiol
|
1995
|
0.89
|
|
16
|
Massive aortic aneurysm presenting as chest wall swelling.
|
Heart
|
2004
|
0.89
|
|
17
|
Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women.
|
Eur J Clin Nutr
|
2011
|
0.88
|
|
18
|
Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
|
CMAJ
|
1999
|
0.85
|
|
19
|
Accurate, reproducible measurement of blood pressure.
|
CMAJ
|
1990
|
0.85
|
|
20
|
From death and disability to patient empowerment: an interprofessional partnership to achieve cardiovascular health in Canada.
|
Can J Public Health
|
2002
|
0.85
|
|
21
|
Achieving cardiovascular health through continuing interprofessional development.
|
Can J Public Health
|
2002
|
0.82
|
|
22
|
Self-measurement of blood pressure: issues related to the training of patients. Canadian Coalition for High Blood Pressure Prevention and Control.
|
Can J Cardiol
|
1995
|
0.81
|
|
23
|
Self-measurement of blood pressure: assessment of equipment. Canadian Coalition for High Blood Pressure Prevention and Control.
|
Can J Cardiol
|
1995
|
0.79
|
|
24
|
The global burden of cardiovascular diseases.
|
Can J Cardiol
|
1999
|
0.78
|
|
25
|
Errors in assessment of blood pressure: sphygmomanometers and blood pressure cuffs.
|
Can J Public Health
|
1995
|
0.78
|
|
26
|
Hypertension recommendations: are they relevant to public health?
|
Can J Public Health
|
2002
|
0.77
|
|
27
|
Errors in assessment of blood pressure: patient factors.
|
Can J Public Health
|
1995
|
0.77
|
|
28
|
The Canadian consensus report on non-pharmacological approaches to the management of high blood pressure.
|
Clin Exp Hypertens A
|
1990
|
0.76
|
|
29
|
Errors in assessment of blood pressure: blood pressure measuring technique.
|
Can J Public Health
|
1995
|
0.76
|
|
30
|
Madurai Area Physicians Cardiovascular Health Evaluation Survey (MAPCHES)--an alarming status.
|
Can J Cardiol
|
2009
|
0.75
|
|
31
|
Disheartening developments on the world stage.
|
CMAJ
|
1997
|
0.75
|
|
32
|
Prevention and control of high blood pressure: challenges and opportunities.
|
CMAJ
|
1995
|
0.75
|
|
33
|
Elevated blood cholesterol and the prevention of heart disease.
|
Can J Cardiol
|
1999
|
0.75
|
|
34
|
24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazem.
|
Cardiovasc Drugs Ther
|
1995
|
0.75
|
|
35
|
The geography of the community sex ratios for young children in Newfoundland.
|
Sci Total Environ
|
1991
|
0.75
|
|
36
|
A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
|
J Clin Pharmacol
|
1987
|
0.75
|
|
37
|
Workshop III: Communicating among health professionals--including health politicians.
|
J Hum Hypertens
|
1995
|
0.75
|
|
38
|
Canadian Consensus Conference on Nonpharmacological Approaches to the Management of High Blood Pressure: recommendations.
|
J Cardiovasc Pharmacol
|
1990
|
0.75
|
|
39
|
Nutrition sense or nonsense?
|
Postgrad Med
|
1987
|
0.75
|
|
40
|
The role of diltiazem in treating hypertension and coronary artery disease: new approaches to preventing first events.
|
Can J Cardiol
|
1997
|
0.75
|
|
41
|
The P-wave in the electrocardiogram of hypertensive patients before and after therapy.
|
Can J Cardiol
|
1986
|
0.75
|
|
42
|
Cardiovascular disease prevention in the elderly.
|
Can J Cardiol
|
1999
|
0.75
|
|
43
|
Efficacy of once daily nitrendipine in mild hypertension: comparison with placebo.
|
Can J Cardiol
|
1991
|
0.75
|
|
44
|
Intersalt in Newfoundland and Labrador.
|
Ann Nutr Metab
|
1990
|
0.75
|
|
45
|
Pharmacoeconomics of hypertension control: basic principles of economic evaluation.
|
J Hum Hypertens
|
1996
|
0.75
|
|
46
|
LDL molecular size as risk factor in coronary artery disease.
|
Acta Med Hung
|
1993
|
0.75
|
|
47
|
Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
|
J Cardiovasc Pharmacol
|
1991
|
0.75
|
|
48
|
Modification of cardiovascular risk factors in rural population of Newfoundland through nutritional counselling.
|
Cor Vasa
|
1991
|
0.75
|
|
49
|
Treatment of mild hypertension.
|
J Cardiovasc Pharmacol
|
1991
|
0.75
|
|
50
|
Adherence to non-pharmacologic therapy for hypertension: problems and solutions.
|
Can J Public Health
|
1999
|
0.75
|
|
51
|
Association analysis of bovine bactericidal/permeability-increasing protein gene polymorphisms with somatic cell score in Holstein cattle.
|
Anim Genet
|
2008
|
0.75
|
|
52
|
25 years follow up of pacing in a toddler.
|
Heart
|
2004
|
0.75
|